Clinical aspects of substance abuse in persons with schizophrenia (Q35084956)

6 August 2017

1 reference

title

Clinical aspects of substance abuse in persons with schizophrenia (English)

1 reference

6 August 2017

1 reference

1 reference

Juan C Negrete

1

1 reference

PubMed ID

12635559

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Canadian Journal of Psychiatry

6 August 2017

1 reference

6 August 2017

48

1 reference

6 August 2017

1

1 reference

6 August 2017

14-21

1 reference

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

6 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Prevalence of smoking among psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Substance abuse and the onset of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Schizophrenia and substance abuse: prevalence issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

How does drug and alcohol misuse develop among people with psychotic illness? A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Psychopathology in dual diagnosis and non-addicted schizophrenics--are there differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Substance misuse, psychiatric disorder and violent and disturbed behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Addiction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Influence of cannabis abuse on schizophrenic psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Using measures of readiness to change in individuals with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Mental health versus substance abuse treatment programs for dually diagnosed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Managing comorbid schizophrenia and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Evidence-based treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Psychosocial approaches to dual diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Treating substance abuse in schizophrenia. An initial report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Olanzapine treatment for patients with schizophrenia and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Significant interaction between clozapine and cocaine in cocaine addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Treatment of the schizophrenia prodrome: is it presently ethical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Attitudes towards alcoholics anonymous by dually diagnosed psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304800104

10.1177/070674370304800104

21 January 2018

Identifiers

DOI

0 references

PubMed ID

12635559

1 reference

PubMed ID

12635559